Nanjing IASO Biotechnology Co., Ltd. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-08
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 4 | |
| Phase 1/2 | 3 | |
| Phase 2 | 1 | |
| Phase 3 | 1 |
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Multiple Myeloma (5) · Non-Hodgkin Lymphoma (2) · Amyloidosis (1) · DLBCL (1) · Leukemia (1) · Lupus (SLE) (1)
Get alerts when Nanjing IASO Biotechnology Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.